Clinical trial Recruiting at 1 site Observational Ages 18 and up

Investigating heart function in patients with a HeartMate 3 device

Official title: Exploration of Intracardiac Geometry and Hemodynamics During HeartMate 3 Therapy: A Novel Approach Using Photon-Counting CT and Computational Fluid Dynamics

Run by Region Östergötland · NCT06115096 · Data updated 2026-11-12

This study is testing how changing the flow levels in the HeartMate 3 device affects heart function and blood flow in patients with heart failure.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment35 (estimated)
SponsorRegion Östergötland
Academic / other
Locations1 site (Linköping, Östergötland County)
StatusRecruiting
StartedMarch 1, 2023
Main results expectedJanuary 1, 2030
Study endsJanuary 1, 2030
Registry record updatedNovember 2, 2023
Trial IDNCT06115096 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old who have been treated with the HeartMate 3 device for more than six months.

Probably not a fit

Patients with reduced kidney function, known iodine contrast allergy, untreated hyperthyroidism, or certain other medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore how different flow levels in the HeartMate 3 left ventricular assist device affect intracardiac geometry and hemodynamics in patients with heart failure. Participants will undergo three photon-counting CT scans and echocardiographic imaging in a single session, while their HeartMate device's flow is varied. The study will analyze three-dimensional geometry and computational fluid dynamics parameters, including blood velocity and pressure, in relation to device settings and patient characteristics. The findings could enhance understanding of cardiac function during mechanical circulatory support.

Why it matters

Potential benefit: If successful, this study could lead to improved monitoring and management of heart failure patients using the HeartMate 3 device.

How similar studies have gone: While the use of advanced imaging techniques in this context is relatively novel, previous studies have shown promise in improving hemodynamic monitoring in heart failure patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Connected to Linköping University Hospital ((situated in the Swedish Southeastern healthcare region)
* Treatment with HeartMate 3 and implanted for \> 6 months ago
* Age \>18 years.

Exclusion Criteria:

* Reduced kidney function (eGFR below 45 ml/min/1.73m2).
* Known iodine contrast allergy
* In case of untreated manifest hyperthyroidism
* In case of suspected/newly diagnosed thyroid cancer where radioiodine examination/treatment may be relevant
* Myasthenia Gravis
* Ongoing pregnancy

Where it's running

  • Linköping University Hospital
    Linköping, Östergötland County, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.